Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive SIMBRINZA with DUOTRAV in Open-Angle Glaucoma or Ocular Hypertension
2016-000176-20Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of brinzolamide + brimonidine in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Change from baseline in diurnal intraocular pressure at week 6. Started Apr 2016; status: terminated.
02
Drugs
brinzolamide + brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2016-000176-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000176-20.